Data resource profile: Cardiovascular H3Africa innovation resource (Chair)

International Journal of Epidemiology

Volumn 48, Issue 2, 2019, Pages 366-367g

  Owolabi, Mayowa O ^a   Akpa, Onoja M ^a   Made, Felix ^b,c   Adebamowo, Sally N ^d   Ojo, Akinlolu ^e   Adu, Dwomoa ^f   Motala, Ayesha A ^g   Mayosi, Bongani M ^h   Ovbiagele, Bruce ⁱ   Adebamowo, Clement ^d,j,k   Tayo, Bamidele ^l   Rotimi, Charles ^m   Akinyemi, Rufus ^a   Gebregziabher, Mulugeta ⁿ   Sarfo, Fred ^o   Wahab, Kolawole W ^p   Parekh, Rulan S ^q   Engel, Mark E ^r   Chisala, Chisala ^r   Peprah, Emmanuel ^s   Mensah, George ^t   Wiley, Ken ^u   Troyer, Jennifer ^m   Ramsay, Michèle ^c   more..

^a UNIVERSITY OF IBADAN   (Nigeria)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF GHANA   (Ghana)

^g UNIVERSITY OF KWAZULU NATAL   (South Africa)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF IBADAN   (Nigeria)

^l LOYOLA UNIVERSITY CHICAGO   (United States)

^m NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

ⁿ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^o KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^p UNIVERSITY OF ILORIN   (Nigeria)

^q UNIVERSITY HEALTH NETWORK   (Canada)

^r UNIVERSITY OF CAPE TOWN   (South Africa)

^s NEW YORK UNIVERSITY   (United States)

^t NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^u Division of Genomic Medicine   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR DISEASE; DIABETES; DISEASE PREVALENCE; EPIDEMIC; ETIOLOGY; MORTALITY; RISK FACTOR;

AFRICA; ARTICLE; BIOBANK; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL RESEARCH; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DATA BASE; DATA COLLECTION METHOD; DATA COMPLETENESS; DISEASE CONTROL; GLOBAL DISEASE BURDEN; GROUPS BY AGE; HEALTH CARE ACCESS; HUMAN; HYPERTENSION; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; PREVALENCE; PRIORITY JOURNAL; BIOMEDICINE; GENETICS; INFORMATION DISSEMINATION;

AFRICA;

AFRICA; BIOLOGICAL SCIENCE DISCIPLINES; BIOLOGICAL SPECIMEN BANKS; CARDIOVASCULAR DISEASES; GENETIC RESEARCH; HUMANS; INFORMATION DISSEMINATION;

EID: 85067568696     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyy261     Document Type: Article

References (39)

1. Roth GA, Johnson C, Abajobir A. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017;70:1-25.
2. Yusuf S, Rangarajan S, Teo K et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 2014;371:818-27.
3. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 2010;35:72-115.
4. World Health Organization. Cardiovascular Diseases (CVDs). Updated May 2017. http://www.who.int/mediacentre/factsheets/fs317/en/ (12 November 2017, date last accessed).
5. Owolabi MO, Bower JH, Ogunniyi A. Mapping Africa's way into prominence in the field of neurology. Arch Neurol 2007;64: 1696-700.
6. Owolabi MO, Mensah GA, Kimmel PL et al. Understanding the rise in cardiovascular diseases in Africa: harmonising H3Africa genomic epidemiological teams and tools. Cardiovasc J Afr 2014;25:134-36.
7. Peprah E, Wiley K, Troyer J et al. Building a platform to enable NCD research to address population health in Africa: CVD Working Group Discussion at the Sixth H3Africa Consortium Meeting in Zambia. Glob Heart 2016;11:165-70.
8. Adebamowo SN, Dareng EO, Famooto AO et al.; ACCME Research Group as part of the H3Africa Consortium. Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study. Int J Epidemiol 2017;46:1745.
9. Ramsay M, Crowther N, Tambo E et al. H3Africa AWI-Gen Collaborative Centre: a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African countries. Glob Health Epidemiol Genom 2016;1:e20.
10. Ekoru K, Young EH, Adebamowo C et al. H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocol. Glob Health Epidemiol Genom 2016;1:e5.
11. Osafo C, Raji YR, Burke D et al. Human Heredity and Health (H3) in Africa kidney disease research network: a focus on methods in sub-saharan Africa. Clin J Am Soc Nephrol 2015;10: 2279-87.
12. Zühlke L, Engel ME, Lemmer CE et al. The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study. BMC Cardiovasc Disord 2016;16:46.
13. Akpalu A, Sarfo FS, Ovbiagele B et al. Phenotyping stroke in sub-saharan Africa: stroke investigative research and education network (SIREN) phenomics protocol. Neuroepidemiology 2015;45:73-82.
14. Oga EA, Brown JP, Brown C et al. Recurrence of cervical intraepi-thelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women. BMC Women's Health 2016;16:25.
15. Pickering TG, Hall JE, Appel LJ et al. Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans. Hypertension 2005;45:142-61.
16. WHO. MONICA Manual Part III: Population Survey. Section 1: Population survey data component. 1997. http://www.thl.fi/publications/monica/manual/part3/iii-1.htm (12 November 2017, date last accessed).
17. Owolabi M, Olowoyo P, Miranda JJ et al. Gaps in hypertension guidelines in low- and middle-income versus high-income countries: a systematic review. Hypertension 2016;68:1328-37.
18. Owolabi M, Miranda JJ, Yaria J, Ovbiagele B. Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism. BMJ Glob Health 2016;1:e000105.
19. Johnson W, Onuma O, Owolabi M, Sachdev S. Stroke: a global response is needed. Bull World Health Organ 2016;94:634-34A.
20. Akinyemi RO, Ovbiagele B, Akpalu A et al. Stroke genomics in people of African ancestry: charting new paths. Cardiovasc J Afr 2015;26:S39-49.
21. Gibbons GH, Sampson UK, Cook NL, Mensah GA. NHLBI perspectives on the growth of heart, lung, blood and sleep conditions in Africa: global and domestic insights, challenges and opportunities. Cardiovasc J Afr 2015;26:S18-20.
22. Hall MD, Dufton AM, Katso RM, Gatsi SA, Williams PM, Strange ME. Strategic investments in non-communicable diseases (NCD) research in Africa: the GSK Africa NCD Open Lab. Cardiovasc J Afr 2015;26:S15-17.
23. Mensah GA, Peprah EK, Sampson UK, Cooper RS. H3Africa comes of age. Cardiovasc J Afr 2015;26:S3-5.
24. Mensah GA, Roth GA, Sampson UK et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013. CVJA 2015;26:S6-10.
25. Mocumbi AO. Rheumatic heart disease in Africa: is there a role for genetic studies? Cardiovasc J Afr 2015;26:S21-26.
26. Owolabi MO, Karolo-Anthony S, Akinyemi R et al. The burden of stroke in Africa: a glance at the present and a glimpse into the future. Cardiovasc J Afr 2015;26:S27-38.
27. Raji Y, Mabayoje O, Bello T. Familial clustering of risk factors for cardiovascular disease among first-degree relatives of patients with chronic kidney disease in a sub-Saharan African population. Cardiovasc J Afr 2015;26:S11-14.
28. Sampson UK, Engelgau MM, Peprah EK, Mensah GA. Endothelial dysfunction: a unifying hypothesis for the burden of cardiovascular diseases in sub-Saharan Africa. Cardiovasc J Afr 2015;26:S56-60.
29. Wonkam A, Makani J, Ofori-Aquah S et al. Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients. Cardiovasc J Afr 2015;26:S50-55.
30. Sarfo F, Gebregziabher M, Ovbiagele B et al. Stroke investigative research educational networks. Multilingual validation of the questionnaire for verifying stroke-free status in West Africa. Stroke 2016;47:167-72.
31. Owolabi MO, Akpa OM, Agunloye AM. Carotid IMT is more associated with stroke than risk calculators. Acta Neurol Scand 2016;133:442-50.
32. Owolabi MO, Sarfo F, Akinyemi F et al. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. Lancet Glob Health 2018;6:e436-46.
33. Kengne AP, Mayosi BM. Modifiable stroke risk factors in Africa: lessons from SIREN. Lancet Glob Health 2018;6:e363-64.
34. Gómez-Olivé FX, Ali SA, Made F et al. Stark regional and sex differences in the prevalence and awareness of hypertension: An H3Africa AWI-gen study across 6 sites in sub-saharan Africa. Glob Heart 2017;12:81.
35. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.
36. Roetzheim RG, Freund KM, Corle DK. Analysis of combined data from heterogeneous study designs: a methodological proposal from the patient navigation research program. Clin Trials 2012;9:176-87.
37. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999;28:1-9.
38. Lappalainen I, Almeida-King J, Kumanduri V et al. The European genome-phenome archive of human data consented for biomedical research. Nat Genet 2015;47:692-95.
39. Beiswanger CM, Abimiku A, Carstens N et al. Accessing biospe-cimens from the H3Africa consortium. Biopreserv Biobank 2017;15:95-98.